2016 中国急诊重症肺炎临床实践专家共识

2016-02-20 中国医师协会急诊医师分会 中国急救医学.2016,36(2):91-107

随着近年来重症肺炎在病原学、病情评估和临床预后等方面研究的不断深入,为更好地指导重症肺炎的治疗,于学忠等制定了本共识,对重症肺炎的诊断、急诊及入院后评估、治疗、治疗后评估及预后等方面进行了阐述。

中文标题:

2016 中国急诊重症肺炎临床实践专家共识

发布日期:

2016-02-20

简要介绍:

重症肺炎(SeVere pneumonia,SP)是由肺组织(细支气管、肺泡、间质)炎症发展到一定疾病阶段,恶化加重形成,引起器官功能障碍甚至危及生命。社区获得性肺炎(community—acquired pneumonia,CAP)、医院获得性肺炎(hospital—acquired pneumonia,HAP)、健康护理(医疗)相关性肺炎(healch care—associated pneumonia,HeAP)和呼吸机相关性肺炎(ventilatorassociated pneumonia,VAP)均可引起重症肺炎,重症肺炎病死率高达30%一50%,可导致严重的并发症,加重医疗经济负担。


重症肺炎救治的首站多为急诊科,并需要呼吸、监护病房、感染、检验等临床多科室协作才能完成。

随着近年来重症肺炎在病原学、病情评估和临床预后等方面研究的不断深入,为更好地指导重症肺炎的治疗,于学忠等参考中华医学会呼吸病学分会2002年《医院获得性肺炎诊断和治疗指南(草案)》、2006年《社区获得性肺炎诊断和治疗指南》、美国IDSA/ATS成人社区获得性肺炎指南、2014年中国严重脓毒症/感染性休克治疗指南及2015年中华医学会呼吸病分会感染学组起草的《社区获得性肺炎诊断和治疗指南》,应用循证医学的方法制定了本共识,对重症肺炎的诊断、急诊及入院后评估、治疗、治疗后评估及预后等方面进行了阐述。

拓展指南:重症肺炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 中国急诊重症肺炎临床实践专家共识)] GetToolGuiderByIdResponse(projectId=1, id=da01e1c0012e10ea, title=2016 中国急诊重症肺炎临床实践专家共识, enTitle=, guiderFrom=中国急救医学.2016,36(2):91-107, authorId=null, author=, summary=随着近年来重症肺炎在病原学、病情评估和临床预后等方面研究的不断深入,为更好地指导重症肺炎的治疗,于学忠等制定了本共识,对重症肺炎的诊断、急诊及入院后评估、治疗、治疗后评估及预后等方面进行了阐述。, cover=, journalId=null, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命,维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作,把分会建成为急诊科医师温馨家园!, copyright=0, guiderPublishedTime=Sat Feb 20 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=重症肺炎(SeVere pneumonia,SP)是由肺组织(细支气管、肺泡、间质)炎症发展到一定疾病阶段,恶化加重形成,引起器官功能障碍甚至危及生命。社区获得性肺炎(community—acquired pneumonia,CAP)、医院获得性肺炎(hospital—acquired pneumonia,HAP)、健康护理(医疗)相关性肺炎(healch care—associated pneumonia,HeAP)和呼吸机相关性肺炎(ventilatorassociated pneumonia,VAP)均可引起重症肺炎,重症肺炎病死率高达30%一50%,可导致严重的并发症,加重医疗经济负担。 <div><br> </div> <div>重症肺炎救治的首站多为急诊科,并需要呼吸、监护病房、感染、检验等临床多科室协作才能完成。</div> <div><br> </div> <div>随着近年来重症肺炎在病原学、病情评估和临床预后等方面研究的不断深入,为更好地指导重症肺炎的治疗,于学忠等参考中华医学会呼吸病学分会2002年《医院获得性肺炎诊断和治疗指南(草案)》、2006年《社区获得性肺炎诊断和治疗指南》、美国IDSA/ATS成人社区获得性肺炎指南、2014年中国严重脓毒症/感染性休克治疗指南及2015年中华医学会呼吸病分会感染学组起草的《社区获得性肺炎诊断和治疗指南》,应用循证医学的方法制定了本共识,对重症肺炎的诊断、急诊及入院后评估、治疗、治疗后评估及预后等方面进行了阐述。</div><div> <br> </div>拓展指南:<strong>与<font color="red">重症肺炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=da01e1c0012e10ea" title="2016 中国急诊重症肺炎临床实践专家共识" target="_blank">2016 中国急诊重症肺炎临床实践专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E" target="_blank">有关重症肺炎更多指南</a></ul>, tagList=[TagDto(tagId=19538, tagName=重症肺炎)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=27923, appHits=1751, showAppHits=9, pcHits=23041, showPcHits=6171, likes=157, shares=75, comments=14, approvalStatus=1, publishedTime=Mon Sep 05 18:07:06 CST 2016, publishedTimeString=2016-02-20, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Sep 05 18:07:06 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:01:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 中国急诊重症肺炎临床实践专家共识)])
2016 中国急诊重症肺炎临床实践专家共识
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207143, encodeId=5fd1120e143ac, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:53:04 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192744, encodeId=06681192e44e9, content=实用性强,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:05:25 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192531, encodeId=3d551192531bc, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:36:14 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077986, encodeId=a94410e798699, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d6162757, createdName=ms6000001867035096, createdTime=Wed Dec 08 08:27:30 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071719, encodeId=912d10e171999, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7473053054, createdName=449152631, createdTime=Fri Nov 19 11:21:29 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-03-30 洁巴子

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207143, encodeId=5fd1120e143ac, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:53:04 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192744, encodeId=06681192e44e9, content=实用性强,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:05:25 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192531, encodeId=3d551192531bc, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:36:14 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077986, encodeId=a94410e798699, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d6162757, createdName=ms6000001867035096, createdTime=Wed Dec 08 08:27:30 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071719, encodeId=912d10e171999, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7473053054, createdName=449152631, createdTime=Fri Nov 19 11:21:29 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-02-12 ms3000000637975859

    实用性强,有效

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207143, encodeId=5fd1120e143ac, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:53:04 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192744, encodeId=06681192e44e9, content=实用性强,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:05:25 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192531, encodeId=3d551192531bc, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:36:14 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077986, encodeId=a94410e798699, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d6162757, createdName=ms6000001867035096, createdTime=Wed Dec 08 08:27:30 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071719, encodeId=912d10e171999, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7473053054, createdName=449152631, createdTime=Fri Nov 19 11:21:29 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-02-11 ms3000000637975859

    非常好,实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207143, encodeId=5fd1120e143ac, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:53:04 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192744, encodeId=06681192e44e9, content=实用性强,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:05:25 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192531, encodeId=3d551192531bc, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:36:14 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077986, encodeId=a94410e798699, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d6162757, createdName=ms6000001867035096, createdTime=Wed Dec 08 08:27:30 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071719, encodeId=912d10e171999, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7473053054, createdName=449152631, createdTime=Fri Nov 19 11:21:29 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-12-08 ms6000001867035096

    谢谢分享,已学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207143, encodeId=5fd1120e143ac, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:53:04 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192744, encodeId=06681192e44e9, content=实用性强,有效, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:05:25 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192531, encodeId=3d551192531bc, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:36:14 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077986, encodeId=a94410e798699, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d6162757, createdName=ms6000001867035096, createdTime=Wed Dec 08 08:27:30 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071719, encodeId=912d10e171999, content=谢谢分享,已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7473053054, createdName=449152631, createdTime=Fri Nov 19 11:21:29 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-11-19 449152631

    谢谢分享,已学习

    0